Publications

Found 565 results
1996
Teja-Isavadharm, P. et al. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. British Journal of Clinical Pharmacology 42, 599-604 (1996).
Price, R. N. et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-8 (1996).
Bethell, D. et al. Electrocardiographic monitoring in severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 266-9 (1996).
Luxemburger, C. et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 105-11 (1996).
Nosten, F. H. & van Vugt, M. . Malaria: still no vaccine and very few drugs. Current Opinion in Infectious Diseases 9, 429-434 (1996).
Luxemburger, C. et al. Mefloquine in infants and young children. Annals of Tropical Paediatrics 16, 281-6 (1996).
Nosten, F. H. et al. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Lancet 348, 701-7 (1996).
1995
Price, R. N. et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 523-7 (1995).
Waller, D. et al. Clinical features and outcome of severe malaria in Gambian children. Clinical Infectious Diseases 21, 577-87 (1995).
McGready, R. & Nosten, F. H. . Falciparum malaria in pregnancy. Australia and New Zealand Journal of Obstetrics and Gynaecology 35, 468-9. (1995).
Ballou, W. R. et al. Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study. PARASITOLOGY 110, S25-36 (1995).
Nosten, F. H. . Halofantrine in the Treatment of Malaria. DRUG SAFETY 13, 271-272 (1995).
Kuile, F. O. Ter et al. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bulletin of the World Health Organization 73, 631-42 (1995).
Nosten, F. H. & Price, R. N. . New antimalarials. A risk-benefit analysis. DRUG SAFETY 12, 264-73 (1995).
Pied, S. et al. Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. Parasite 2, 263-8 (1995).
Luxemburger, C. , Nosten, F. H. , Raimond, S. D. , Chongsuphajaisiddhi, T. & White, N. J. . Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. American Journal of Tropical Medicine and Hygiene 53, 522-5 (1995).
Kuile, F. O. Ter et al. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 660-4 (1995).
1994
Nosten, F. H. . Artemisinin: large community studies. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 Suppl 1, S45-6 (1994).
Kuile, F. O. Ter et al. Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography. American Journal of Tropical Medicine and Hygiene 51, 778-84 (1994).
Krishna, S. et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 67-73 (1994).
Nosten, F. H. et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study. Journal of Infectious Diseases 169, 595-603 (1994).
Luxemburger, C. et al. Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 213-7 (1994).
Nosten, F. H. et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3- day artesunate-mefloquine combination. Journal of Infectious Diseases 170, 971-7 (1994).

Pages

 

Contact

Shoklo Malaria Research Unit
68/30 Bantung Road, PO Box 46
Mae Sot, Tak 63110 Thailand

Tel: +66 (0) 55 532 026
       +66 (0) 55 532 028
Fax: +66 (0) 55 532 027
Email SMRU

Zircon - This is a contributing Drupal Theme
Design by WeebPal.